InsiderDB

Exact Sciences (EXAS)

Healthcare · Medical - Diagnostics & Research

2 members of Congress have disclosed 11 trades in Exact Sciences (EXAS) since 2022: 2 buys and 9 sales. The most recent was disclosed on Apr 3, 2026.

Trades disclosed
11
Members trading
2
Buys / sells
2 / 9
Reported value
$60K–$250K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow EXAS

What else is happening at EXAS

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. EXASLobbying report·Lobbying disclosures

    EXAS: third_quarter 2026 lobbying report

    H.R.7118 Genomic Answers for Children's Health Act H.R.7118 Genomic Answers for Children's Health Act FY27 MilCon-VA appropriations Access to colorectal cancer screening tests

    Public: Oct 16, 2026, 11:03 PM EDTOriginal source ↗
  2. EXASLobbying report·Lobbying disclosures

    EXAS: second_quarter 2026 lobbying report

    H.R.7118 Genomic Answers for Children's Health Act H.R.7118 Genomic Answers for Children's Health Act FY27 MilCon-VA appropriations Access to colorectal cancer screening tests

    Public: Jul 18, 2026, 7:41 PM EDTOriginal source ↗

Who traded EXAS

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.